About Cell & Gene
CellandGene.com is where stakeholders come to discover the most important trends and technologies in this burgeoning field. Content in this community spans the entire product lifecycle from basic research to commercialization.
Monthly Unique Users
Monthly Page Views
Leads Generated Through Partner Content Engagement In 2020
Our readers are scientists and executives who work in Manufacturing, CMC, R&D, Cell Line Development, and the C-suite. They are experts in this new form of molecular medicine, working to cure the inherited or acquired diseases through delivering therapeutic genes to targeted cells and replacing the disorder genes.
Meet the Chief Editor: Erin Harris
If you’re passionate about the lifecycle of cell and gene therapies - from basic research through commercialization - then you’re going to want to meet our Chief Editor, Erin Harris. She interviews the key players in the cell and gene therapy space and writes about the most pressing issues. Here’s a sample of her latest articles for Cell & Gene.
Erin is also a contributing editor to Life Science Leader magazine. She studied English and psychology at Lafayette College and has 20+ years of experience in B2B publishing. Erin spent 10 years covering and reporting on the adoption of information technology from a B2B perspective. She’s written on technology topics ranging from Big Data and analytics to security and e-commerce. In each case, her reporting centered on innovations that improved operational efficiencies, fostered interdepartmental collaboration, or enhanced supply chains. Currently, she writes actionable information for professionals involved in the development and commercialization of cell and gene therapies. She covers the entire product lifecycle from basic research to commercialization. Erin has interviewed executives from Fortune 500 as well as startups. She has moderated panel discussions and has spoken at numerous industry events from large conferences to niche forums.
Other Recommended Communities
We believe in publishing the advice that helps our readers get their drugs and therapies to patients faster - the kinds of content that can't be slotted into a monthly editorial calendar. Instead, here's an overview of the topics frequently published in this community.
We don't have one! We believe media kits are relics of the old-school B2B publishing model. B2B sales and marketing has changed drastically since our company was founded nearly 40 years ago. The way we produce and deliver information to our readers has changed too. Media kits have been replaced by the data-driven, highly customized products, services, and content we produce for our increasingly sophisticated strategic partners. Instead, we ask that you connect with us to learn more about how we drive business outcomes beyond vanity metrics and cold leads. You can read more about why we don't publish media kits on our Follow Your Buyer site - an online community dedicated to our methodology of engaging your buyers.
Let's work together.
Whether you're ready to hit the ground running or just starting and have questions, we're here to understand your goals and explore how we can help you.